Clinical Trials Browser

INDUSTRY × Breast Neoplasms × Surgical Procedures, Operative × Clear all

NCT05415215 2026-02-10

ProHer

Phase 3 Completed

346 enrolled 20 charts

Breast Neoplasms, Patient Preference, Inflammatory Breast Neoplasms

NCT03725059 2025-07-11

KEYNOTE-756

Phase 3 Active not recruiting

Breast Neoplasms

NCT04109066 2025-01-08

CheckMate 7FL

Phase 3 Completed

521 enrolled 17 charts

Breast Neoplasms, Neoplasms

NCT03493854 2024-06-26

FeDeriCa

Phase 3 Completed

500 enrolled 28 charts 2 FDA

Breast Neoplasms

NCT03272477 2024-04-17

TP-II

Phase 2 Completed

Breast Neoplasms

NCT02586025 2023-05-22

PEONY

Phase 3 Completed

329 enrolled 33 charts

Breast Neoplasms

NCT03916744 2023-03-10

A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer

Phase 1 Completed

75 enrolled 24 charts

Breast Neoplasms

NCT01142778 2018-03-16

AVATAXHER

Phase 2 Completed

Breast Neoplasms

NCT00849472 2014-03-04

Treatment With Pazopanib for Neoadjuvant Breast Cancer

Phase 2 Completed

101 enrolled 16 charts

Breast Neoplasms

NCT00191789 2010-07-27

Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer

Phase 2 Completed

65 enrolled 13 charts

Breast Neoplasms

NCT00161980 2006-10-23

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites

Phase 3 Completed

Breast Neoplasms, Seroma